{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T04:54:09Z","timestamp":1781931249414,"version":"3.54.5"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.ygyno.2005.05.002","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T16:19:55Z","timestamp":1119975595000},"page":"179-181","source":"Crossref","is-referenced-by-count":65,"title":["Society of Gynecologic Oncologists Clinical Practice Committee Statement on Prophylactic Salpingo-oophorectomy"],"prefix":"10.1016","volume":"98","member":"78","reference":[{"key":"10.1016\/j.ygyno.2005.05.002_bib1","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2005.05.002_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2005.05.002_bib3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2005.05.002_bib4","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2005.05.002_bib5","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/95.14.1072","article-title":"Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study","volume":"95","author":"Rutter","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2005.05.002_bib6","first-page":"3776","article-title":"Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations","volume":"8","author":"Satagopan","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2005.05.002_bib7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2005.05.002_bib8","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","article-title":"Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers","volume":"91","author":"Rebbeck","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2005.05.002_bib9","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.2000.18.14.2728","article-title":"Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy","volume":"18","author":"Lu","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.05.002_bib10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2005.05.002_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.05.002_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/gyno.2002.6638","article-title":"Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy","volume":"85","author":"Colgan","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.05.002_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/gyno.2000.6095","article-title":"A genetic epidemiological study of carcinoma of the fallopian tube","volume":"80","author":"Aziz","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.05.002_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ygyno.2003.12.009","article-title":"Defining cancer risks for BRCA germline mutation carriers: implications for surgical prophylaxis","volume":"92","author":"Karlan","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.05.002_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2003.11.009","article-title":"BRCA germline mutations in Jewish women with uterine serous papillary carcinoma","volume":"92","author":"Lavie","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.05.002_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1525-1438.2003.t01-1-13050.x","article-title":"Longitudinal CA125 detection of sporadic papillary serous carcinoma of the peritoneum","volume":"13","author":"Skates","year":"2003","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805003227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805003227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T09:16:20Z","timestamp":1551518180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825805003227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0090825805003227"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2005.05.002","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}